Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $263,309 | 135 | 56.9% |
| Consulting Fee | $110,085 | 37 | 23.8% |
| Travel and Lodging | $61,652 | 203 | 13.3% |
| Food and Beverage | $26,485 | 951 | 5.7% |
| Unspecified | $1,111 | 7 | 0.2% |
| Education | $107.92 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $231,626 | 488 | $0 (2024) |
| Janssen Products, LP | $123,644 | 148 | $0 (2023) |
| ViiV Healthcare Company | $63,527 | 219 | $0 (2024) |
| Merck Sharp & Dohme LLC | $32,093 | 118 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $5,584 | 12 | $0 (2020) |
| Janssen Biotech, Inc. | $1,414 | 98 | $0 (2023) |
| Janssen Research & Development, LLC | $975.93 | 6 | $0 (2017) |
| PFIZER INC. | $865.07 | 68 | $0 (2022) |
| ABBVIE INC. | $474.18 | 28 | $0 (2022) |
| EMD Serono, Inc. | $412.08 | 24 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,625 | 23 | Gilead Sciences, Inc. ($28,544) |
| 2023 | $44,002 | 74 | Gilead Sciences, Inc. ($40,549) |
| 2022 | $27,500 | 64 | Gilead Sciences, Inc. ($15,128) |
| 2021 | $25,172 | 64 | Gilead Sciences, Inc. ($16,190) |
| 2020 | $26,664 | 93 | Gilead Sciences, Inc. ($12,097) |
| 2019 | $101,682 | 281 | Gilead Sciences, Inc. ($54,059) |
| 2018 | $121,346 | 373 | Janssen Products, LP ($42,968) |
| 2017 | $87,761 | 363 | Janssen Products, LP ($36,203) |
All Payment Transactions
1,335 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $590.00 | General |
| Category: HIV | ||||||
| 11/13/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: HIV | ||||||
| 10/04/2024 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,840.00 | General |
| 09/24/2024 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $287.74 | General |
| 09/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 09/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $142.83 | General |
| 09/06/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $885.00 | General |
| Category: HIV | ||||||
| 07/24/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: HIV | ||||||
| 07/12/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: HIV | ||||||
| 06/03/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: HIV | ||||||
| 05/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.84 | General |
| 05/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.82 | General |
| 05/02/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: HIV | ||||||
| 04/25/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: HIV | ||||||
| 04/23/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $102.88 | General |
| Category: HIV | ||||||
| 04/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $97.41 | General |
| 04/20/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,750.00 | General |
| Category: HIV | ||||||
| 04/20/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,750.00 | General |
| Category: HIV | ||||||
| 03/27/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: HIV | ||||||
| 03/22/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: HIV | ||||||
| 03/05/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: HIV | ||||||
| 03/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.59 | General |
| 01/17/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: HIV | ||||||
| 12/29/2023 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| 12/15/2023 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $440.00 | General |
| Category: HIV | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE III, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY | ViiV Healthcare Company | $1,111 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 51 | 83 | $15,294 | $7,786 |
| 2022 | 3 | 94 | 151 | $30,265 | $14,021 |
| 2021 | 3 | 184 | 306 | $36,430 | $20,813 |
| 2020 | 6 | 319 | 504 | $52,605 | $25,950 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 72 | $13,248 | $6,414 | 48.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $2,046 | $1,372 | 67.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 105 | $19,845 | $9,022 | 45.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 32 | $8,544 | $4,102 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 14 | $1,876 | $897.38 | 47.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 122 | 240 | $33,688 | $19,003 | 56.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 17 | $1,607 | $945.64 | 58.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 48 | 49 | $1,135 | $864.43 | 76.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 141 | 297 | $40,095 | $19,587 | 48.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 75 | $6,943 | $3,354 | 48.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 14 | $2,534 | $1,030 | 40.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 59 | 60 | $1,380 | $930.04 | 67.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 29 | 29 | $725.00 | $567.82 | 78.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 29 | 29 | $928.00 | $480.82 | 51.8% |
About Dr. Thanes Vanig, MD
Dr. Thanes Vanig, MD is a Medical healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215925441.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thanes Vanig, MD has received a total of $462,751 in payments from pharmaceutical and medical device companies, with $28,625 received in 2024. These payments were reported across 1,335 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($263,309).
As a Medicare-enrolled provider, Vanig has provided services to 648 Medicare beneficiaries, totaling 1,044 services with total Medicare billing of $68,570. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Medical
- Other Specialties Infectious Disease
- Location Phoenix, AZ
- Active Since 10/11/2005
- Last Updated 08/09/2018
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1215925441
Products in Payments
- Symtuza (Drug) $54,676
- Descovy (Drug) $47,029
- Biktarvy (Drug) $33,548
- PREZCOBIX (Drug) $27,094
- ISENTRESS (Drug) $24,287
- SYMTUZA (Drug) $17,485
- DOVATO (Drug) $9,953
- Genvoya (Drug) $7,832
- TIVICAY (Drug) $6,681
- PREZISTA (Drug) $5,677
- DELSTRIGO (Drug) $2,517
- PIFELTRO (Drug) $2,257
- TRIUMEQ (Drug) $1,879
- Odefsey (Drug) $1,625
- JULUCA (Drug) $555.27
- CHANTIX (Drug) $527.96
- SEROSTIM (Biological) $292.71
- Vascepa (Drug) $292.54
- Androgel (Drug) $215.94
- VRAYLAR (Drug) $176.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Phoenix
Scott Young, Pa, PA
Medical — Payments: $55,738
Jennifer Kiser, Pac, PAC
Medical — Payments: $46,703
Lakeisha Colter, Pa-C, PA-C
Medical — Payments: $24,645
Ty Nielson
Medical — Payments: $13,838
Ms. Brittany Silverman, Pa, PA
Medical — Payments: $12,882
John Rimer, Pa-C, PA-C
Medical — Payments: $11,846